NSE: DRREDDY

DRREDDY: Riding the Semaglutide Wave in a Competitive Indian Market

By StreetVantage Intelligence // March 22, 2026

₹₹1298.95

NEUTRAL

DISCLAIMER: Educational intelligence only. StreetVantage is NOT SEBI registered. Trading involve risk of loss.